logo
logo

axialHealthcare Announces $15 Million in Series C Funding to Support Expansion into Substance Use Disorder Treatment and Recovery Sector

Feb 27, 2020•over 5 years ago

Amount Raised

$15 Million

Round Type

series c

Nashville

Description

axialHealthcare, a care optimization company navigating substance use issues for patients, providers, and health plans, today announced it has closed $15 million in equity financing to accelerate its expansion into the substance use disorder (SUD) treatment and recovery sector, led by previous institutional investors Oak HC/FT, .406 Ventures, BlueCross BlueShield Venture Partners (BCBSVP), and Sandbox Advantage Fund. The company also announced it has launched a new modernized brand identity that reflects the company’s expanded scope, both of which are designed to meet the needs of patients, providers, and health plans during the evolving opioid overdose epidemic.

Company Information

Company

Axial Healthcare

Location

Nashville, Arkansas, United States

About

axialHealthcare connects patients, providers, and health plans with an end-to-end platform that covers the entire substance use spectrum. Leveraging services grounded in analytics, our risk to recovery platform identifies patients at risk, prevents escalation in their condition, and supports appropriate treatment enrollment and adherence. This high-tech, high-touch approach delivers measurable clinical and financial outcomes by effectively managing cost of care while supporting sustained recovery for patients with substance use disorder. For more information, visit www.axialhealthcare.com.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People